Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

09989 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

5.030
+0.060+1.21%
Market Close 10/05 16:08 CCT
High
5.250
Open
5.000
Turnover
1.70M
Low
4.990
Pre Close
4.970
Volume
337.50K
Market Cap
7.38B
P/E(TTM)
15.20
52wk High
8.899
Shares
1.47B
P/E(Static)
25.02
52wk Low
4.970
Float Cap
1.11B
Bid/Ask %
38.46%
Historical High
19.259
Shs Float
220.09M
Volume Ratio
1.67
Historical Low
4.970
Dividend TTM
0.041
Div Yield TTM
0.041
P/B
0.52
Dividend LFY
0.82%
Div Yield LFY
0.82%
Turnover Ratio
0.15%
Amplitude
5.23%
Avg Price
5.024
Lot Size
500
Float Cap
1.11B
Bid/Ask %
38.46%
Historical High
19.259
Shs Float
220.09M
Volume Ratio
1.67
Historical Low
4.970
Dividend TTM
0.041
P/B
0.52
Dividend LFY
0.82%
Turnover Ratio
0.15%
Amplitude
5.23%
Avg Price
5.024
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Shenzhen Hypri Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company with business in heparin sodium preparation and API, macromolecular drug contract development and production organization (CDMO) and innovative drug development. The company's main products and services include enoxaparin sodium preparations and heparin sodium raw materials, enoxaparin sodium raw materials, and macromolecular drug CDMO services. The company's products are sold in the domestic market and overseas markets, including Turkey, Brazil and the United States.
CEO: Li Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...